Progressive Metastatic Prostate Cancer
Oncology·MeSH: Bulbo-Spinal Atrophy, X-Linked
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Progressive Metastatic Prostate Cancer?
There are 1 clinical trial targeting Progressive Metastatic Prostate Cancer tracked by BioSniper.
What is the prevalence of Progressive Metastatic Prostate Cancer?
The estimated prevalence of Progressive Metastatic Prostate Cancer is approximately 256.0 per 100,000 population.
Deep-dive into Progressive Metastatic Prostate Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis